British Drugmaker
Jun 05, 2010 at 15:40 | Source: Reuters
Photos »
/ 
News across the web »
Dec 21, 2011 at 16:36 | Source: Reuters-India
Dec 21, 2011 at 15:46 | Source: Reuters
Dec 21, 2011 at 11:41 | Source: Reuters-India
Dec 21, 2011 at 11:41 | Source: Reuters
Dec 21, 2011 at 06:27 | Source: CHILL-WEIRD NEWS Reuters
Interact & exchange stock tips & market info »
to shepherd the British drugmaker`s experimental medici...
5.35 PM Dec 21st 2011
for it. Pasteris is one of 25 executives appointed last year to sheph...
9.23 PM Dec 24th 2011
Related News »
Human Genome said its board determined the $13-a-share bid by the British drugmaker was inadequate and undervalued the company and it recommended stockholders not tender their shares. Glaxo, however, said it plans to proceed with its tender ...
May 17, 2012 at 17:46 | Source: msnbc.com
backing a 52.5 million euro EU antitrust fine for the British drugmaker. The European Commission imposed the penalty on AstraZeneca in 2005, saying the company had given misleading information related to Losec, a bestseller at the time ...
May 15, 2012 at 11:22 | Source: Reuters
The British drugmaker's payment will depend on how much the gel's sales exceed a revenue forecast established by the companies. Auxilium also will make other payments to Glaxo that were not specified. Auxilium now expects its 2012 net loss to ...
May 26, 2012 at 08:03 | Source: Yahoo Finance
GSK would gain full control of these assets in a HGS buyout, but other buyers of HGS would have to share them with the British drugmaker. "I still think it is very likely that they will have to pay more," Mark Evans, a Taube Hodson Stonex fund ...
May 8, 2012 at 23:55 | Source: FierceBiotech
When British field hockey goalkeeper Abi Walker isn’t trying ... MacLeod, 27, also worked for GlaxoSmithKline Plc (GSK), the U.K.’s biggest drugmaker, as a sports scientist on its Lucozade energy drink. She left last November to dedicate ...
May 17, 2012 at 09:54 | Source: Businessweek
Status: Agreed - GSK CONDITIONS HUMAN GENOME BID ON POISON PILL BEING DROPPED British drugmaker GlaxoSmithKline Plc (LON:GSK) said it had added as a condition to its USD13.00 (EUR10.35) a share hostile takeover offer for Human Genome Sciences (NASDAQ ...
May 24, 2012 at 13:20 | Source: comcast.net
Last year, British drugmaker GlaxoSmithKline announced that it expects to reach a bigger settlement this year related to its development and promotion of the diabetes drug Avandia, among others. Abbott’s settlement marks the culmination of a ...
May 8, 2012 at 01:58 | Source: Bangor Daily News
the British firm's revenues for the year ending September 30, 2012 will be materially below the company's expectations. * ASTRAZENECA - The drugmaker plans to seal several new deals this year to fill its flagging pipeline of experimental ...
May 21, 2012 at 06:50 | Source: Reuters UK
British gilt futures, seen as a safe-haven ... with utilities National Grid and drugmaker Shire up 0.2 and 0.3 percent respectively.
May 18, 2012 at 07:58 | Source: International Business Times
Drugmaker Elan Corporation ... Bankia's shares were suspended, while British lenders Royal Bank of Scotland and Lloyds Banking Group fell up to 4.1 percent. Basic resource stocks, also down 20 percent in the last 3 months on the back global ...
May 25, 2012 at 16:32 | Source: Reuters UK